These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6737423)

  • 1. Aporphines. 58. N-(2-chloroethyl) [8,9-2H]norapomorphine, an irreversible ligand for dopamine receptors: synthesis and application.
    Guan JH; Neumeyer JL; Filer CN; Ahern DG; Lilly L; Watanabe M; Grigoriadis D; Seeman P
    J Med Chem; 1984 Jun; 27(6):806-10. PubMed ID: 6737423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of [3H]N-(chloroethyl)-norapomorphine to rat striatal membranes.
    Kilpatrick GJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1984 Dec; 107(1):71-8. PubMed ID: 6084599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Haloaporphines as potent dopamine agonists.
    Ramsby S; Neumeyer JL; Grigoriadis D; Seeman P
    J Med Chem; 1989 Jun; 32(6):1198-201. PubMed ID: 2524592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
    George SR; Watanabe M; Seeman P
    J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aporphines, 36. Dopamine receptor interactions of trihydroxyaporphines. Synthesis, radioreceptor binding, and striatal adenylate cyclase stimulation of 2,10,11-trihydroxyaporphines in comparison with other hydroxylated aporphines.
    Neumeyer JL; Arana GW; Law SJ; Lamont JS; Kula NS; Baldessarini RJ
    J Med Chem; 1981 Dec; 24(12):1440-5. PubMed ID: 7310821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of (-)N-(chloroethyl)-norapomorphine on [3H]-apomorphine binding to striatal dopamine receptors.
    Goosey MW; Doggett NS
    Biochem Pharmacol; 1982 Nov; 31(22):3693-4. PubMed ID: 7181954
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary.
    Dumbrille-Ross A; Seeman P
    Biochem Pharmacol; 1987 Jul; 36(13):2095-9. PubMed ID: 2955789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible interaction of beta-haloalkylamine derivatives with dopamine D1 and D2 receptors.
    Cross AJ; Waddington JL; Ross ST
    Life Sci; 1983 Jun; 32(24):2733-40. PubMed ID: 6222234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of [3H]spiperone binding sites in the intermediate lobe of the rat pituitary gland.
    Lightman SL; Ninkovic M; Hunt SP
    Neurosci Lett; 1982 Oct; 32(2):99-102. PubMed ID: 7145239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine.
    Gao Y; Zong R; Campbell A; Kula NS; Baldessarini RJ; Neumeyer JL
    J Med Chem; 1988 Jul; 31(7):1392-6. PubMed ID: 3385732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between behavioral effects of (-)-N-(2-chloroethyl)-norapomorphine and D2 dopamine receptor-like activity.
    Helmeste DM
    Eur J Pharmacol; 1983 Nov; 95(3-4):277-81. PubMed ID: 6317413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alloxan-induced diabetes on dopaminergic receptors in rat striatum and anterior pituitary.
    Serri O; Renier G; Somma M
    Horm Res; 1985; 21(2):95-101. PubMed ID: 3979949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aporphines. 50. Kinetics of solvolysis of N-(2-chloroethyl)norapomorphine, an irreversible dopamine receptor antagonist.
    Cohen SA; Neumeyer JL
    J Med Chem; 1983 Oct; 26(10):1348-53. PubMed ID: 6620296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptors modulating [3H]acetylcholine release in slices of the cat caudate: effects of (-)-N-(2-chloroethyl)-norapomorphine.
    Lehmann J; Lee CR; Langer SZ
    Eur J Pharmacol; 1983 Jun; 90(4):393-400. PubMed ID: 6884428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 125I-Spiperone: a novel ligand for D2 dopamine receptors.
    Gundlach AL; Largent BL; Snyder SH
    Life Sci; 1984 Nov; 35(19):1981-8. PubMed ID: 6149442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel radioiodinated high affinity ligand for the D2-dopamine receptor. Characterization of its binding in bovine anterior pituitary membranes.
    Amlaiky N; Kilpatrick BF; Caron MG
    FEBS Lett; 1984 Oct; 176(2):436-40. PubMed ID: 6548453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R and S enantiomers of 11-hydroxy- and 10,11-dihydroxy-N-allylnoraporphine: synthesis and affinity for dopamine receptors in rat brain tissue.
    Neumeyer JL; Gao YG; Kula NS; Baldessarini RJ
    J Med Chem; 1991 Jan; 34(1):24-8. PubMed ID: 1671415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.